105 related articles for article (PubMed ID: 11102952)
1. Z-1,1-Dichloro-2,3-diphenylcyclopropanes block human prostate carcinoma cell proliferation, inhibit prostate-specific antigen expression, and initiate apoptosis.
Balachandran R; Grant SG; Welsh MJ; Day BW
Prostate; 2000 Dec; 45(4):277-88. PubMed ID: 11102952
[TBL] [Abstract][Full Text] [Related]
2. Induction of human breast cancer cell apoptosis from G2/M preceded by stimulation into the cell cycle by Z-1,1-dichloro-2,3-diphenylcyclopropane.
Balachandran R; ter Haar E; Yalowich JC; Welsh MJ; Grant SG; Day BW
Biochem Pharmacol; 1999 Jan; 57(1):97-110. PubMed ID: 9920290
[TBL] [Abstract][Full Text] [Related]
3. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin.
ter Haar E; Hamel E; Balachandran R; Day BW
Anticancer Res; 1997; 17(3C):1861-9. PubMed ID: 9216636
[TBL] [Abstract][Full Text] [Related]
4. The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145.
Cattaneo-Pangrazzi RM; Schott H; Schwendener RA
Prostate; 2000 Sep; 45(1):8-18. PubMed ID: 10960838
[TBL] [Abstract][Full Text] [Related]
5. (Z)-1,1-Dichloro-2-(4-methoxyphenyl)-3-phenylcyclopropane induces concentration-dependent growth inhibition, apoptosis, and coordinates regulation of apoptotic genes in TRAMP cells.
Thomas CA; Grant SG; Pflug BR; Getzenberg RH; Day BW
Urol Oncol; 2008; 26(4):378-85. PubMed ID: 18367102
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway.
Kim IY; Seong DH; Kim BC; Lee DK; Remaley AT; Leach F; Morton RA; Kim SJ
Cancer Res; 2002 Jul; 62(13):3649-53. PubMed ID: 12097269
[TBL] [Abstract][Full Text] [Related]
7. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
[TBL] [Abstract][Full Text] [Related]
8. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.
Hsieh TC; Wu JM
Exp Cell Res; 1999 May; 249(1):109-15. PubMed ID: 10328958
[TBL] [Abstract][Full Text] [Related]
9. Decrease in prostate specific antigen secretion correlated with docetaxel-induced growth inhibition and apoptosis in human prostate tumor cells.
Noguchi K; Shakuto S; Sakairi T; Yoshida Y
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1863-70. PubMed ID: 19920389
[TBL] [Abstract][Full Text] [Related]
10. Effects of fenretinide (4-HPR) on prostate LNCaP cell growth, apoptosis, and prostate-specific gene expression.
Hsieh TC; Wu JM
Prostate; 1997 Oct; 33(2):97-104. PubMed ID: 9316650
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells.
Robertson CN; Roberson KM; Padilla GM; O'Brien ET; Cook JM; Kim CS; Fine RL
J Natl Cancer Inst; 1996 Jul; 88(13):908-17. PubMed ID: 8656443
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells.
Gupta S; Ahmad N; Nieminen AL; Mukhtar H
Toxicol Appl Pharmacol; 2000 Apr; 164(1):82-90. PubMed ID: 10739747
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts.
Pinski J; Parikh A; Bova GS; Isaacs JT
Cancer Res; 2001 Sep; 61(17):6372-6. PubMed ID: 11522628
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin.
Chan FL; Choi HL; Chen ZY; Chan PS; Huang Y
Cancer Lett; 2000 Nov; 160(2):219-28. PubMed ID: 11053652
[TBL] [Abstract][Full Text] [Related]
15. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibitory activity of lemnabourside on human prostate cancer cells.
Liu WK; Wong NL; Huang HM; Ho JK; Zhang WH; Che CT
Life Sci; 2002 Jan; 70(7):843-53. PubMed ID: 11837251
[TBL] [Abstract][Full Text] [Related]
18. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
19. Genistein inhibits tamoxifen effects on cell proliferation and cell cycle arrest in T47D breast cancer cells.
Jones JL; Daley BJ; Enderson BL; Zhou JR; Karlstad MD
Am Surg; 2002 Jun; 68(6):575-7; discussion 577-8. PubMed ID: 12079141
[TBL] [Abstract][Full Text] [Related]
20. Unique formosan mushroom Antrodia camphorata differentially inhibits androgen-responsive LNCaP and -independent PC-3 prostate cancer cells.
Chen KC; Peng CC; Peng RY; Su CH; Chiang HS; Yan JH; Hsieh-Li HM
Nutr Cancer; 2007; 57(1):111-21. PubMed ID: 17516868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
